IDiyas

For the Inventor, By the Inventor

Nanjing, China

Frank Wu

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 1.6

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Novi, MI (US) (2016 - 2018)
  • Nanjing, CN (2016 - 2023)

Company Filing History:

goldMedal7 out of 7 
 
Nanjing Transthera Biosciences Co. Ltd.
 patents
silverMedal3 out of 25,901 
 
Ford Global Technolgoies, LLC
 patents
bronzeMedal3 out of 6 
 
Transthera Sciences (nanjing), Inc.
 patents

Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 12465601 - Uses of phosphodiesterase inhibitors (2025-11-11),
2. 12371432 - Haloallylamine compounds and application thereof (2025-07-29),
3. 11718620 - Method for treating a cancer mediated by abnormality of multi-kinases (2023-08-08),
4. 11649233 - Halo-allylamine SSAO/VAP-1 inhibitor and use thereof (2023-05-16),
5. 11434248 - PDE9 inhibitor and use thereof (2022-09-06),
6. 11046679 - Indoleamine 2,3-dioxygenase inhibitor and application (2021-06-29),
7. 10889591 - PDE9 inhibitor and use thereof (2021-01-12),
8. 10889586 - Multi-kinase inhibitor compound, and crystal form and use thereof (2021-01-12),
9. 10744139 - Inhibitors of fibroblast growth factor receptor and use thereof (2020-08-18),
10. 10208042 - Multi-kinase inhibitor compound, and crystal form and use thereof (2019-02-19),
11. 10007478 - System and methods for voice-controlled seat adjustment (2018-06-26),
12. 9469228 - Seat climate control assembly and seat employing the same (2016-10-18),
13. 9463747 - Compartment panel assembly and vehicle employing the same (2016-10-11),

Title: Frank Wu: Innovator in Pharmaceutical Sciences

Introduction

Frank Wu is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals, holding a total of 13 patents. His work focuses on developing innovative treatments for various medical conditions, particularly those related to heart failure.

Latest Patents

One of Frank Wu's latest patents is centered on the uses of phosphodiesterase inhibitors. This invention discloses a compound represented by a general formula and its pharmaceutically acceptable salts, isomers, and deuterated compounds. The compound has shown promise in treating heart failure diseases by improving heart function in rats, reversing myocardial remodeling, and reducing fibrosis in the marginal zone of infarction. Another notable patent involves haloallylamine compounds, which are relevant in the pharmaceutical field. This invention relates to a halo-allylamine compound and its various forms, including salts and esters. The patent outlines its application in preventing and treating diseases mediated by the SSAO/VAP-1 protein.

Career Highlights

Frank Wu has worked with several notable companies throughout his career. He has been associated with Nanjing Transthera Biosciences Co. Ltd. and Ford Global Technologies, LLC. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Frank Wu has collaborated with several professionals in his field, including Lin Li and Xiaoju Yang. These collaborations have further enhanced his research and development efforts in pharmaceuticals.

Conclusion

Frank Wu is a distinguished inventor whose work in pharmaceuticals has led to significant advancements in treating heart failure and related diseases. His innovative patents and collaborations reflect his commitment to improving medical treatments and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…